{{Rsnum
|rsid=246221
|Gene=ABCC1
|Chromosome=16
|position=16044465
|Orientation=plus
|GMAF=0.4444
|Gene_s=ABCC1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 40.7 | 49.6
| HCB | 25.0 | 39.0 | 36.0
| JPT | 13.3 | 55.8 | 31.0
| YRI | 55.8 | 35.4 | 8.8
| ASW | 42.1 | 43.9 | 14.0
| CHB | 25.0 | 39.0 | 36.0
| CHD | 22.9 | 45.9 | 31.2
| GIH | 1.0 | 30.7 | 68.3
| LWK | 47.7 | 43.1 | 9.2
| MEX | 10.3 | 44.8 | 44.8
| MKK | 34.0 | 50.0 | 16.0
| TSI | 9.8 | 47.1 | 43.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=21929509
|Title=ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
}}

{{PMID Auto
|PMID=16684361
|Title=Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region.
|OA=1
}}

{{PMID Auto
|PMID=23396606
|Title=Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}